SE8402561L - Farmaceutisk komposition - Google Patents

Farmaceutisk komposition

Info

Publication number
SE8402561L
SE8402561L SE8402561A SE8402561A SE8402561L SE 8402561 L SE8402561 L SE 8402561L SE 8402561 A SE8402561 A SE 8402561A SE 8402561 A SE8402561 A SE 8402561A SE 8402561 L SE8402561 L SE 8402561L
Authority
SE
Sweden
Prior art keywords
alkyl
pharmaceutical composition
ester
pyrrolidone
aliphatic
Prior art date
Application number
SE8402561A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8402561D0 (sv
Inventor
J Heller
W A Skinner
K Saito
S Satoh
Y Takakura
Y Itoh
Original Assignee
Nitto Electric Ind Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Electric Ind Co filed Critical Nitto Electric Ind Co
Publication of SE8402561D0 publication Critical patent/SE8402561D0/xx
Publication of SE8402561L publication Critical patent/SE8402561L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8402561A 1983-05-20 1984-05-11 Farmaceutisk komposition SE8402561L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49673283A 1983-05-20 1983-05-20

Publications (2)

Publication Number Publication Date
SE8402561D0 SE8402561D0 (sv) 1984-05-11
SE8402561L true SE8402561L (sv) 1984-11-21

Family

ID=23973888

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8402561A SE8402561L (sv) 1983-05-20 1984-05-11 Farmaceutisk komposition

Country Status (8)

Country Link
CA (1) CA1225594A (fr)
CH (1) CH657531A5 (fr)
DE (1) DE3418565C2 (fr)
DK (1) DK239984A (fr)
FR (1) FR2547503B1 (fr)
GB (1) GB2141025B (fr)
NL (1) NL8401422A (fr)
SE (1) SE8402561L (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4637930A (en) * 1984-02-08 1987-01-20 Yamanouchi Pharmaceutical Co, Ltd. Transdermal formulation of nicardipine hydrochloride
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
US4826686A (en) * 1985-12-14 1989-05-02 Boehringer Ingelheim Kg Therapeutic system
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
US4861764A (en) * 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
GB8718886D0 (en) * 1987-08-10 1987-09-16 Ici America Inc Composition
CA1334646C (fr) * 1988-04-08 1995-03-07 James Vanolden Peck Produits stimulant la penetration transdermique
US5246949A (en) * 1989-12-06 1993-09-21 Sansho Co., Ltd. Preparation for endermism containing dopamine derivatives
JPH03236317A (ja) * 1989-12-06 1991-10-22 Sansei Seiyaku Kk ドパミン誘導体含有経皮用製剤
AU6410494A (en) * 1993-03-17 1994-10-11 Alza Corporation Device for the transdermal administration of alprazolam
DE4432429A1 (de) * 1994-09-12 1996-03-14 Heinz Prahm Arzneimittel enthaltend S-Milchsäure und dessen Verwendung
US5693335A (en) * 1995-06-07 1997-12-02 Cygnus, Inc. Skin permeation enhancer composition for use with sex steroids
DE19949202A1 (de) * 1999-10-13 2001-05-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Acetylsalicylsäure und/oder Salicylsäure
EP1931417A2 (fr) * 2005-09-30 2008-06-18 Transcutaneous Technologies Inc. Systemes d'administration transdermique de medicament, dispositifs, et methodes faisant intervenir de nouveaux excipients pharmaceutiques
JP2009522011A (ja) 2005-12-30 2009-06-11 Ｔｔｉ・エルビュー株式会社 活性物質を生体界面に送達するイオントフォレーシスシステム、装置及び方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1158283A (en) * 1965-10-21 1969-07-16 Foster Milburn Company Composition to be Applied to Skin and Process for Preparing Same.
FR2001768A1 (fr) * 1968-02-12 1969-10-03 Gillette Co Compositions pour l'application topique de medicaments sur la peau
SE325667B (fr) * 1968-03-06 1970-07-06 Medisan Ab
US3472931A (en) * 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides
GB1404583A (en) * 1971-10-08 1975-09-03 Vymatt Sa Urea compositions and methods of preparation thereof
GB1504302A (en) * 1974-08-23 1978-03-15 Fisons Ltd Sedative method and composition
US3932653A (en) * 1974-12-19 1976-01-13 Nelson Research & Development Co. Composition and method for topical administration of griseofulvin
US3957994A (en) * 1974-12-19 1976-05-18 Nelson Research & Development Company Topical anti-inflammatory composition and method of use
US4017641A (en) * 1975-01-31 1977-04-12 The Procter & Gamble Company Skin moisturizing compositions containing 2-pyrrolidinone
GB1538903A (en) * 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4038417A (en) * 1975-06-19 1977-07-26 Nelson Research & Development Company Method for treatment of psoriasis
CA1165240A (fr) * 1980-07-09 1984-04-10 The Procter & Gamble Company Composes pharmaceutiques a usage topique
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion

Also Published As

Publication number Publication date
CH657531A5 (de) 1986-09-15
DK239984A (da) 1984-11-21
FR2547503B1 (fr) 1987-11-20
DE3418565C2 (de) 1992-05-27
DK239984D0 (da) 1984-05-15
GB2141025B (en) 1986-09-17
NL8401422A (nl) 1984-12-17
GB8412569D0 (en) 1984-06-20
DE3418565A1 (de) 1984-11-22
FR2547503A1 (fr) 1984-12-21
GB2141025A (en) 1984-12-12
CA1225594A (fr) 1987-08-18
SE8402561D0 (sv) 1984-05-11

Similar Documents

Publication Publication Date Title
SE8402561D0 (sv) Farmaceutisk komposition
SE8403487D0 (sv) Farmaceutisk komposition
PT88962A (pt) Aparelho aperfeicoado de libertacao transdermica de medicamentos
DE2964438D1 (en) Method of making solid medicaments with active agents applied in form of drops
TR199500826A2 (tr) Multipl ünite tablet doz formu 2.
ES2097546T3 (es) Preparaciones cosmeticas desodorantes que contienen esteres di- o trigliceridos.
DE3681755D1 (de) Wirkstofftraeger und diesen enthaltende arzneimittel.
CS145091A3 (en) Isoxazole-4-carboxamides and amides of hydroxyalkylidene cyanacetic acid, medicaments comprising said compounds and their application
ES2032382T3 (es) Metodo para preparar un medicamento para la prevencion o tratamiento de la endometriosis.
IL80437A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing them
YU47116B (sh) Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata
FI864815A0 (fi) Medel foer bestaemning av peroxidasaktiviteten tillsammans med en stabilsator, dess framstaellningsfoerfarande och anvaendning.
AR010399A1 (es) DERIVADOS DE AMIDAS DE LOS ÁCIDOS ISOXAZoLICO Y CROToNICO , PROCEDIMIENTO PARA SU PREPARACIoN MEDICAMENTO QUE LOS CONTIENE Y SU UTILIZACIoN COMO MEDICAMENTOS Y COMO AGENTES DE DIAGNoSTICO
IT7831446A0 (it) Acidi omega-amminoalcanoil-omega-ammino-a lcanoici n-sostituiti, loro impiego e procedimenti per la loro preparazione e anche prodotti medicinali contenenti questi composti.
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
IT1107805B (it) Procedimento per la preparazione di un farmaco attivo contro la nevrosi da ansieta o simile e medicamento avente tale attivita
MX9206816A (es) Derivados de cromano substituidos con piperidilmetilo, procedimiento para su obtencion y medicamentoque los contiene.
KR910021361A (ko) 항궤양 물질
GB2021409A (en) Pharmaceutical composition
IT1164176B (it) Composizione per un'applicazione topica contenente,come sostanza attiva sull'elasticia',la morbidezza della pelle tiamorfolinone oppure uno dei suoi derivati
SE8403488D0 (sv) Farmaceutisk komposition
KR890009395A (ko) 흡입제
ES2128353T3 (es) Composicion topica que contiene penciclovir.
MX9204816A (es) Procedimiento para la aplicacion controlada de sustancias activas por iontoforesis y dispositivo para realizar tal aplicacion.
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8402561-8

Effective date: 19880917